ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2333

Risk of Incident Myocardial Infarction Among Disabled Patients with Rheumatoid Arthritis Who Were Beneficiaries of the Social Security Disability Insurance

Iris Navarro-Millan1, Mangala Rajan 1, Geyanne Lui 1, Lisa Kern 1, Laura Pinheiro 1, Sebastian E. Sattui 2, Lisa Mandl 3, Fenglong Xie 4, Jeffrey Curtis 5 and Monika Safford 1, 1Weill Cornell Medicine, New York, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, 4University of Alabama at Birmingham, Birmingham, 5University of Alabama at Birmingham, Birmingham, AL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cardiovascular disease and myocardial infarction, Disability, Medicare, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with RA have high risk for myocardial infarction (MI). A meta-analysis showed that the age and sex adjusted pooled relative risk of MI among patients with RA was 1.69, 95% confidence interval (CI) 1.50 – 1.90. There is limited understanding about the prevalence and incidence of MI events among individuals younger than 65 years of age disabled (defined as beneficiaries of the social security disability insurance (SSDI)) with RA. 

Among patients with RA < 65 years of age who receive SSDI benefits in 2011, to 1) determine the prevalence of cardiovascular disease (CVD) and CVD risk factors; and 2) among those free of CVD at baseline, to compare the risk of incident MI among those with and without CVD risk factors at baseline, to compare the risk of incident MI among those with and without CVD risk factors at baseline.

Methods: We analyzed claims data of the SSDI beneficiaries aged 18-64 years of age with RA, defined as ≥2 ICD-9 CM codes (714.xx) from a rheumatologist > 7 and < 365 days apart, OR 1 ICD-9-CM code from a rheumatologist AND a DMARD in 2011 in a period > 7 and < 365 days. Prevalent CVD was defined by ICD-9-CM code from heart failure, stroke, or CVD procedures (coronary artery bypass grafting, percutaneous coronary intervention, or carotid endartherectomy) in 2011. We used the chronic conditions data warehouse to identify CVD risk factors (ICD-9-CM codes for diabetes, hyperlipidemia, hypertension, obesity) in 2011. We followed subjects without prevalent CVD in 2011, through 2014 to determine incident MI, defined as the first hospitalization for MI (discharge diagnosis ICD-9-CM codes 410.xx). Age adjusted incidence rates were estimated using Poisson models. Age- and sex-adjusted Cox proportional hazard model was used to compare the risk for incident MI between patients with and without CVD factors at baseline.

Results: There were 48,905 patients in the study sample; 78.9% were female, 72.2% were ≤60 years of age, and 69% had at least one CVD risk factor, with hypertension being the most prevalent (52.7%) (Table 1). The prevalence of CVD was 9.3% (N = 4,528). Among the 44,377 without CVD at baseline, 28,538 (64%) had baseline CVD risk factors; 433 MI events occurred among those with CVD risk factors and 143 among those without over 35.9 median months of follow-up (Table 2). The age-adjusted incident rate of MI was 5.02 (95% CI 4.52 – 5.58) per 1000 person-years for those with CVD risk factors and 3.42 (95% CI 2.90 – 4.03) per 1000 person-years for those without CVD risk factors. The age- and sex-adjusted hazard ratio (HR) for incident MI for those with CVD risk factors compared to those without was 1.47 (95% CI 1.22-1.78).

Conclusion: The prevalence of CVD and CVD risk factors was high in this population of disabled individuals younger than 65 years of age with RA. The incident rate for MI was high in the subgroup of patients without CVD risk factors considering that 80% of those patients were 60 year of age or younger (3.42 per 1000 person-year). As expected, patients with CVD risk factors were 47% more likely to experience an MI compare to patients without CVD risk factors.


Table 1 ACR abstract_v2

Table 1: Characteristics of 48,905 Patients with RA <65 Years of Age receiving Social Security Disability Insurance Benefits in 2011, with and without Cardiovascular Disease -CVD- Risk Factors


Table 2 ACR abstract

Table 2: Three-Year Incidence of Myocardial Infarction among Patients with Rheumatoid Arthritis <65 Years of Age Receiving Social Security Disability Insurance Benefits and Free of Cardiovascular Disease at Baseline


Disclosure: I. Navarro-Millan, None; M. Rajan, None; G. Lui, None; L. Kern, None; L. Pinheiro, None; S. Sattui, None; L. Mandl, Annals of Internal Medicine, 3, Annals of Internal Medicine- Associate Editor, 3, UpToDate, 7, Wolters Kluwer - Author at UptoDate, 7, Wolters Kluwer - Author at UpToDate, 7, Wolters Kluwer- Author at UpToDate, 7; F. Xie, None; J. Curtis, AbbVie, 2, 5, Abbvie, 2, 5, AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Lilly, Janssen, Myriad, Pfizer, Regeneron, Roche, and UCB, 2, 5, Amgen, 2, 5, Amgen Inc., 2, 5, BMS, 2, 5, Bristol-Myers Squibb, 2, 5, Corrona, 2, 5, Crescendo, 2, 5, Eli Lilly, 2, 5, Eli Lilly and Company, 2, 5, Genentech, 2, 5, Janseen, 5, Janssen, 2, 5, Janssen Research & Development, LLC, 2, Lilly, 2, 5, Myriad, 2, 5, Patient Centered Outcomes Research Insitute (PCORI), 2, Pfizer, 2, 5, Radius Health, Inc., 9, Regeneron, 2, 5, Roche, 2, 3, 5, Roche/Genentech, 5, UCB, 2, 5; M. Safford, Amgen, 2, 9.

To cite this abstract in AMA style:

Navarro-Millan I, Rajan M, Lui G, Kern L, Pinheiro L, Sattui S, Mandl L, Xie F, Curtis J, Safford M. Risk of Incident Myocardial Infarction Among Disabled Patients with Rheumatoid Arthritis Who Were Beneficiaries of the Social Security Disability Insurance [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/risk-of-incident-myocardial-infarction-among-disabled-patients-with-rheumatoid-arthritis-who-were-beneficiaries-of-the-social-security-disability-insurance/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-incident-myocardial-infarction-among-disabled-patients-with-rheumatoid-arthritis-who-were-beneficiaries-of-the-social-security-disability-insurance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology